Lifei Pian segmentation by type classifies the product into three core categories—herbal extracts, processed powders, and ready‑to‑use formulations—each containing sub‑types that affect manufacturing complexity and price points. Herbal extracts are divided into ethanol‑based, water‑based, and supercritical CO₂ extracts; ethanol‑based extracts dominate with ~55 % of type‑level revenue due to higher yield of lipophilic actives, while water‑based extracts capture ~30 % owing to regulatory preference for aqueous preparations. Supercritical CO₂ extracts, though niche at ~15 %, command premium pricing for their solvent‑free profile. Processed powders comprise fine‑grade, micro‑encapsulated, and spray‑dried variants; fine‑grade powders hold the largest share (~60 %) as they are directly incorporated into supplements, whereas micro‑encapsulation (~25 %) adds stability for functional foods, and spray‑drying (~15 %) supports large‑scale food‑industry applications. Ready‑to‑use formulations include tinctures, lozenges, and topical gels; tinctures represent ~70 % of this sub‑segment, lozenges ~20 %, and gels ~10 %, reflecting consumer convenience trends. Understanding these type‑level distributions is critical for precise market sizing and for aligning R&D investments with the most profitable sub‑types within the Lifei Pian market, a key element of market taxonomy.
